P2X7 receptor: an emerging target in central nervous system diseases.

Sperlágh, Beáta and Illes, P. (2014) P2X7 receptor: an emerging target in central nervous system diseases. TRENDS IN PHARMACOLOGICAL SCIENCES, 35 (10). pp. 537-547. ISSN 0165-6147

Preview

Text sperlágh1.pdf Download (949kB) | Preview

Abstract

The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex. However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathology. There is an explosion of data indicating that genetic deletion and pharmacological blockade of P2X7Rs alter responsiveness in animal models of neurological disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease. Moreover, recent studies suggest that P2X7Rs regulate the pathophysiology of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathology.

Actions (login required)

Edit Item